Oral Bioavailability 2011
DOI: 10.1002/9781118067598.ch29
|View full text |Cite
|
Sign up to set email alerts
|

Intestinal Perfusion Methods for Oral Drug Absorptions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 51 publications
0
1
0
Order By: Relevance
“…Of various in vitro assay systems to measure intestinal permeability, human colorectal adenocarcinoma cells (Caco-2), Madin−Darby canine kidney cells (MDCK), and parallel artificial membrane permeability assay (PAMPA) are commonly used [9], and they can be affected by factors such as cell line types and cultured conditions. The in situ single-pass intestinal perfusion (SPIP) model is the most prevalent assay [17] that normally measures effective permeability (P eff ) of the gastrointestinal (GI) tract segments, namely duodenum, jejunum, ileum, and colon, in human, rat, and mouse [18]. The parameter P eff , which is expressed as cm/s, can be calculated by…”
Section: Introductionmentioning
confidence: 99%
“…Of various in vitro assay systems to measure intestinal permeability, human colorectal adenocarcinoma cells (Caco-2), Madin−Darby canine kidney cells (MDCK), and parallel artificial membrane permeability assay (PAMPA) are commonly used [9], and they can be affected by factors such as cell line types and cultured conditions. The in situ single-pass intestinal perfusion (SPIP) model is the most prevalent assay [17] that normally measures effective permeability (P eff ) of the gastrointestinal (GI) tract segments, namely duodenum, jejunum, ileum, and colon, in human, rat, and mouse [18]. The parameter P eff , which is expressed as cm/s, can be calculated by…”
Section: Introductionmentioning
confidence: 99%